Voyageur Pharmaceuticals (CVE:VM) Shares Up 21.2% – Should You Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shot up 21.2% on Friday . The company traded as high as C$0.21 and last traded at C$0.20. 292,294 shares were traded during trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 21.2 %

The firm has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The business has a 50-day moving average of C$0.10 and a two-hundred day moving average of C$0.07.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.